Compugen hosts virtual KOL event on COM701 in ovarian cancer
CGEN•Virtual KOL event planned for October 5
Compugen will host a virtual KOL event on October 5, 2026 at 8:00 a.m. ET focused on COM701 in ovarian cancer.
Harvard Medical School’s Oladapo Yeku will join management to discuss the evolving ovarian cancer treatment landscape.
The session will also include an update on expanded capabilities of the Unigen AI/ML target discovery platform.
